SpectRx, Inc.'s Light-Based Cervical Cancer Test Promising

NORCROSS, Ga., , Georgia April 25 (UPI) -- U.S. firm SpectRx said Wednesday its non-invasive test for cervical cancer -- which uses light to detect disease -- works better than the Pap test alone. The company said the new technology when used with the Pap test was better at differentiating diseased tissue from healthy tissue than a combination of the Pap and human papillomavirus tests. >>> Discuss This Story